We are live on
!
Find out more
JE
JMAC Enterprises Portfolio holdings
AUM
$522M
1-Year Est. Return
15.34%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
+15.34%
3 Year Est. Return
+52.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$364M
AUM Growth
+$7.42M
(+2.1%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
37.94%
Holding
180
New
8
Increased
28
Reduced
112
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackrock
BLK
|
+$244K |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$219K |
| 3 |
Air Products & Chemicals
APD
|
+$217K |
| 4 |
iShares US Healthcare ETF
IYH
|
+$217K |
| 5 |
DuPont de Nemours
DD
|
+$211K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.56M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.38M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$881K |
| 4 |
Invesco CurrencyShares Australian Dollar Trust
FXA
|
+$843K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$801K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.67% |
| 2 | Technology | 4.79% |
| 3 | Consumer Staples | 3.26% |
| 4 | Financials | 2.07% |
| 5 | Consumer Discretionary | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
EPAM Systems
EPAM
$4.63B
| – | – |
-565
| Closed | -$205K |
|
177
FedEx
FDX
$74.7B
| – | – |
-2,100
| Closed | -$312K |
|
178
Gilead Sciences
GILD
$167B
| – | – |
-10,050
| Closed | -$620K |
|
179
PACCAR
PCAR
$66.4B
| – | – |
-3,750
| Closed | -$209K |
|
180
T. Rowe Price
TROW
$25.1B
| – | – |
-4,708
| Closed | -$494K |
|
Similar funds
LT
SC
TCM
GS
WFA
SCM
SW
ETS
JMAC Enterprises's Q4 2022 Portfolio in Review
As of Q4 2022, JMAC Enterprises held 180 positions worth $364M, up 2.1% from $356M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
JMAC Enterprises withdrew a net $21.6M in Q4 2022, closing 6 positions and reducing 112 holdings. Its most notable exit was Gilead Sciences, an estimated $620K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, JMAC Enterprises opened a new position in Blackrock worth $259K.
- JMAC Enterprises's largest Q4 2022 buy was Blackrock: 365 shares worth $259K.
- JMAC Enterprises added most to Air Products & Chemicals in Q4 2022, an estimated $217K increase.
- JMAC Enterprises's biggest Q4 2022 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $1.56M.
- JMAC Enterprises fully exited Gilead Sciences in Q4 2022, selling an estimated $620K.
- JMAC Enterprises's ten largest holdings make up 38% of its $364M portfolio in Q4 2022.
- JMAC Enterprises opened 8 new positions and closed 6 in Q4 2022.
- JMAC Enterprises's portfolio value rose 2.1% quarter-over-quarter to $364M.
Based on JMAC Enterprises's 13F filing for Q4 2022, filed 23 Jan 2023.